Blocknomi
Key Takeaways Shares of AbCellera surged 32% to $9.12 following positive Phase 2 trial results for menopause drug ABCL635 ABCL635 delivered a single 600mg dose that decreased hot flash frequency…
Related articles
-
ENS Labs Scales Back Treasury Proposal After Delegate Pushback
NewsBTC Published 31.07.2026 19:45
-
Datavault AI Inc. (DVLT) Stock: Company Taps Ron Goldstein to Lead NIL Sports Licensing Push
Blocknomi Published 27.07.2026 17:29
-
Why Stacks’ Bitcoin staking plan could reshape STX demand
Crypto.News Published 03.08.2026 13:31
-
KOSPI Circuit Breakers: How Korea Handles Extreme Volatility
Crypto Daily Published 31.07.2026 11:01
-
ADP: US Private Payrolls Add Just 44,000 Jobs in July
Crypto Daily Published 06.08.2026 10:01
-
Sui to add post-quantum signature schemes for quantum-safe accounts
The Block Published 07.08.2026 02:09
-
Coldcard Losses Near $114M as Small Bitcoin Transfers Spike
Decrypt Published 03.08.2026 10:15
-
Tom Lee vs Jordi Visser on the AI Trade: Both End Up at Ethereum
BeInCrypto Published 31.07.2026 12:39